Sort
53,477 grants matching “addiction”
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
$1,354,901Zihai Li · Ohio State University · P01 · FY2019 · CA
Corticostriatal mechanisms of action learning and habit formation
$1,354,708David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Synaptic Transmission: Modulation, Plasticity And Effects Of Drugs Of Abuse
$1,354,708David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Scientific and Statistical Computing Core
$1,354,014Robert Cox · National Institute Of Mental Health · ZIC · FY2015 · MH
Coordinated medical treatment of opioid use disorder and infectious disease
$1,353,900Sandra Ann Springer · Yale University · U01 · FY2020 · TR
Development of positive TMEM97 modulators for treating neuropathic pain
$1,352,240Stephen Martin · Nuvonuro Inc · UG3 · FY2023 · NS
The Central Virginia Center on Drug Abuse Research
$1,352,218William L Dewey · Virginia Commonwealth University · P30 · FY2020 · DA
The Central Virginia Center on Drug Abuse Research
$1,352,037William L Dewey · Virginia Commonwealth University · P30 · FY2019 · DA
IGNITE Cost Extension - Admin Supplement
$1,351,790Larisa Humma Cavallari · University Of Florida · U01 · FY2023 · HG
Health Systems Node of the NIDA Clinical Trials Network
$1,351,122Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2024 · DA
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse
$1,351,080Kah-Whye Peng · Mayo Clinic Rochester · UH3 · FY2019 · DA
OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T
$1,350,572Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2022 · DA
Iron-CLAD: securely advancing AoU participant characterization with proven platforms and collaborations
$1,349,987Melissa A Haendel · Univ Of North Carolina Chapel Hill · OT2 · FY2025 · OD
Molecular Mechanisms Of Growth Control And Carcinogenesis
$1,349,334J. Silvio Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)
$1,349,130Charles Chiedu Nwaokobia · Evon Medics, Llc · R44 · FY2024 · NS
Ethanol and nicotine co-abuse: cross sensitization of their reinforcing actions
$1,348,982William Joseph McBride · Indiana University Indianapolis · RC2 · FY2009 · AA
Scientific and Statistical Computing Core
$1,348,802Robert Cox · National Institute Of Mental Health · ZIC · FY2014 · MH
Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders
$1,348,795Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · UH3 · FY2024 · DA
Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
$1,348,648Pietro P Sanna · Scripps Research Institute, The · U01 · FY2023 · DA
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$1,348,462Kenner Rice · National Institute On Drug Abuse · ZIA · FY2017 · DA
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
$1,348,453Denis Evseenko · University Of Southern California · R61 · FY2023 · NS
Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
$1,348,437Pietro P Sanna · Scripps Research Institute, The · U01 · FY2025 · DA
Single nucleus gene expression in moderate and compulsive opioid self-administration in a rodent model of HIV
$1,348,437Pietro P Sanna · Scripps Research Institute, The · U01 · FY2024 · DA
Drugs On Learned & Spontaneous Behavior Of Experimental Animals
$1,347,861Steven R Goldberg · National Institute On Drug Abuse · Z01 · FY2008 · DA
Control Of Behavior By Drug Injection
$1,347,861Steven R Goldberg · National Institute On Drug Abuse · Z01 · FY2008 · DA